Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ozanimod
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ozanimod 230microgram caps and Ozanimod 460microgram caps
0802040BFAAABAB
|
Ozanimod | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Ozanimod 920microgram capsules
0802040BFAAAAAA
|
Ozanimod | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Zeposia 0.23mg/0.46mg capsules treatment initiation pack
0802040BFBBABAB
|
Zeposia | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Zeposia 0.92mg capsules
0802040BFBBAAAA
|
Zeposia | Ozanimod | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.